IP Library Patent Application 16259923
Patent Application
App. No. 16/259,923

METHOD FOR PREDICTING CYTOTOXICITY OF COLD ATMOSPHERIC PLASMA TREATMENT ON CANCER CELLS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/259,923
Abstract

A method for applying cold atmospheric plasma treatment to target tissue comprising the steps of selecting through a graphical user interface on a computing device a particular cancer cell line associated with said target tissue, retrieving, with said computing device, settings data from a database of cell line data and associated settings data in a storage, applying, with said computing device, said retrieved settings data to a cold atmospheric plasma system, and treating cancer tissue with cold atmospheric plasma at the retrieved settings.

Claims (21)

1 . A method for applying cold atmospheric plasma treatment to target tissue comprising:

selecting through a graphical user interface a particular cancer cell line associated with target tissue;

retrieving, with said computing device, settings data from a database of cell line data and associated settings data in a storage; and

applying, with said computing device, said retrieved settings data to a cold atmospheric plasma system.

2 . A method for applying cold atmospheric plasma treatment to target tissue comprising:

generating a database of cancer cell lines and associated cold atmospheric plasma settings;

storing said database in a storage medium;

selecting through a graphical user interface on a computing device a particular cancer cell line associated with said target tissue;

retrieving, with said computing device, settings data from a database of cell line data and associated settings data in a storage; and

applying, with said computing device, said retrieved settings data to a cold atmospheric plasma system.

3 . A method for applying cold atmospheric plasma treatment to target tissue according to claim 2 , wherein said predicted CAP effectiveness comprises H 2 O 2 consumption rate of cancer cells after CAP treatment.

4 . A method for applying cold atmospheric plasma treatment to target tissue according to claim 2 , wherein said cold atmospheric plasma settings in said generated database are based upon a predicted CAP effectiveness derived an H 2 O 2 consumption rate of cancer cells in a particular cancer cell line after CAP treatment.

5 . A method for applying cold atmospheric plasma treatment to target tissue according to claim 2 , wherein said cold atmospheric plasma settings in said generated database are based upon a predicted CAP effectiveness derived predicting cytotoxicity of cold atmospheric plasma treatment on particular cancer cell lines.

6 . A method for applying cold atmospheric plasma treatment to target tissue according to claim 2 , wherein said step of generating a database comprises:

removing all medium used to culture a plurality of samples of a first cancer cell line;

adding DMEM or RPMI to each of said plurality of samples of said first cancel cell line;

treating each of said plurality of samples of said first cancer cell line with direct CAP treatment, wherein each of said plurality of samples of said first cancer cell line is treated using only one of a plurality of specific sets of CAP settings and wherein at least two of said plurality of samples of said first cancer cell line are treated with different specific sets of CAP settings;

adding a pre-determined amount of H 2 O 2 -containing medium to each of plurality of samples of said first cancer cell line;

culturing said plurality of samples of said first cancer cell line for a pre-determined period of time under pre-determined conditions;

measuring an H 2 O 2 consumption rate by cancer cells in each treated sample of said first cancer cell line; and

predicting optimum CAP settings for said first cancer cell line using obtained measurements of H 2 O 2 consumption rate by cancer cells in each treated sample of said first cancer cell line.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 29, 2019
From: CANADY, JEROME, DR.; KEIDAR, MICHAEL
To: US PATENT INNOVATIONS, LLC
Reel/Frame 049020/0719 →